Estimated read time: 2-3 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
[STK]
[IN] HEA MTC
[SU] AVO SVY CHI
-- WITH PHOTO -- TO BUSINESS, AND HEALTH EDITORS:
CBR Announces Poster Presentation at the 2014 BMT Tandem Meetings
SAN BRUNO, Calif., Feb. 26, 2014 /PRNewswire/ -- Cord Blood Registry@
(CBR@) announces that the company's abstract submission titled
Prevalence of Diseases and Conditions Amenable to Stem Cell Transplant
or Infusion Among Families Storing Newborn Stem Cells at a Large
Private Cord Blood Bank has been accepted for poster presentation at
the combined annual meetings of the Center for International Blood and
Marrow Transplant Research (CIBMTR) and the American Society of Blood
and Marrow Transplantation (ASBMT), being held February 26 - March 2
in Grapevine, Texas.
The poster, which presents key findings from a recent survey of
families with at least one child who has newborn stem cells stored
with CBR, is scheduled for presentation during the pediatric disorders
session on Wednesday, February 26. Of the families completing the
questionnaire, 1.87% reported an immediate family history of at least
one transplant indication and 17.04% reported at least one
regenerative indication. The research results provide evidence that
among families who store newborn stem cells in private cord blood
banks, conditions for which stem cell transplant or infusion may be
indicated or under investigation are relatively prevalent, especially
for regenerative indications.
CIBMTR is a voluntary research organization of basic and clinical
scientists collaborating to provide a unique resource of data and
statistical expertise to the scientific community for addressing
important issues in hematopoietic cell transplantation.
ASBMT is an international professional membership association of more
than 2,000 physicians, investigators and other healthcare
professionals promoting blood and marrow transplantation and cellular
therapy research, education, scholarly publication and clinical
standards.
Press releases created by third-parties do not necessarily represent
the thoughts and/or opinions of the ASBMT or the CIBMTR.
About Cord Blood Registry Cord Blood Registry@ (CBR@) is the world's
largest newborn stem cell company. Founded in 1992, CBR is entrusted
by parents with storing more than 500,000 cord blood and cord tissue
units. CBR is dedicated to advancing the clinical application of
newborn stem cells by partnering with leading research institutions to
establish FDA-regulated clinical trials, requiring CBR processed cord
blood, for conditions that have no cure today. For more information,
visit cordblood.com
Contact Information: Brian Plummer Manager, Public Relations &
Corporate Communications (650) 635-1420 | EXT. 255
BPlummer@cordblood.com
Photo - http://photos.prnewswire.com/prnh/20131216/DC33657LOGO-a
SOURCE Cord Blood Registry
-0- 02/26/2014
/Photo: http://photos.prnewswire.com/prnh/20131216/DC33657LOGO-a
/Web Site: http://www.cordblood.com
CO: Cord Blood Registry
ST: California
IN: HEA MTC
SU: AVO SVY CHI
PRN
-- DC72300 --
0000 02/26/2014 14:00:00 EDT http://www.prnewswire.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.








